‘Super weight loss’ drug retatrutide could be available soon
KENT COUNTY, Mich — A new weight loss drug could soon be joining the growing list of medications…
Cholesterol-Lowering Pill: US FDA nod for 1st pill to replace jabs to fight high cholesterol | India News
NEW DELHI: Patients with difficult-to-control high cholesterol could soon have an oral alternative to cholesterol-lowering injections after US…
VELMENI Receives FDA 510(k) Clearance for AI-Powered 3D CBCT Dental Imaging Software
The FDA clearance, issued under 510(k), expands VELMENI’s dental AI portfolio into three-dimensional cone-beam computed tomography, or CBCT,…
First Cholesterol-Lowering Pill to Replace PCSK9 Injections Gets US Nod | India News
(Representative image) US FDA approves world’s first oral PCSK9 inhibitor (Photo: IANS). NEW DELHI: Patients with difficult-to-control high…
New Baldness Pill Boosts Hair Coverage by Up to 86% in Six Months
AI-generated image. A familiar hair-loss drug may be getting a major upgrade. A slow-release formulation of minoxidil, one…
Industry and regulators signal a smarter, collaborative era for supplement oversight
While the industry has spent years bracing for and fending off a heavier regulatory hand, what it heard…
FDA-approved GLP-1 pill offers cheaper, needle-free option for weight loss
KENT COUNTY, Mich. — A new oral version of the weight loss drug Wegovy has been approved by…
SuppCo launches certification to verify actives in dietary supplements
The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals – Endpoints News
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals Endpoints NewsCompass Pathways to Announce New…
Milestone Pharma gets FDA approval for first PSVT nasal spray
Milestone (Nasdaq: MIST) announced FDA approval of CARDAMYST (etripamil) nasal spray for conversion…
BioCryst wins FDA OK for ORLADEYO oral pellets in HAE kids
BioCryst (NASDAQ:BCRX) announced FDA approval (Dec 12, 2025) of ORLADEYO oral pellets (berotralstat)…
FDA approves pill which can prevent heart attack, stroke by reducing inflammation: How it works
The U.S. Food and Drug Administration (FDA) has made a major move in heart health care by approving…